In a study aiming to potentiate the antitumor effects of cAMP-agonists, leptin induced apoptosis in MDA-MB-231 breast cancer cells when cAMP levels were increased (22), which resulted in ERK1/2 inactivation and the subsequent inhibition of protein kinase A (PKA) expression (23). Here, MAPK3 is linked to breast carcinoma.